Enantiodetermination of R,S-3,4-methylenedioxypyrovalerone in urine samples by high pressure in-line solid-phase extraction capillary electrophoresis-mass spectrometry

dc.contributor.authorPérez-Alcaraz, Albert
dc.contributor.authorBorrull, Francesc
dc.contributor.authorAguilar, Carme
dc.contributor.authorCalull, Marta
dc.contributor.authorBenavente Moreno, Fernando J. (Julián)
dc.date.accessioned2021-01-18T10:27:18Z
dc.date.available2022-12-14T06:10:27Z
dc.date.issued2020-12-14
dc.date.updated2021-01-18T10:27:18Z
dc.description.abstractThis study presents for the first time an in-line solid-phase extraction capillary electrophoresis-mass spectrometry (SPE-CE-MS) method for the enantiodetermination of drugs of abuse in urine samples. The enantioseparation of R,S-3,4-methylenedioxypyrovalerone (R,S-MDPV) was achieved with a 10 mM ammonium acetate BGE (pH 7) that contained 0.5% (m/v) of sulphated-α-CD as chiral selector. At these pH conditions, this CD was negatively charged, which prevented its entrance into the mass spectrometer since it migrates in the opposite direction. To improve sensitivity, an in-line SPE-CE-MS method using high pressure for sample introduction (i.e. 20 min at 3 bars) was developed. Furthermore, the conditioning procedure and the first part of the electrophoretic separation were performed by switching off the nebulizer gas and the ionization source voltage to avoid non-volatile contaminant arrival into the mass spectrometer. The developed methodology was validated by analyzing urine samples, which required a very simple liquid-liquid extraction (LLE) sample pretreatment. Linearity ranged from 30 to 250 ng/mL, limit of detection (LOD) was 10 ng/mL, relative standard deviation (RSD) values were below 10.5% in terms of intra-day and inter-day precision and the relative error values were below 9% for peak areas accuracy.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec704991
dc.identifier.issn0039-9140
dc.identifier.urihttps://hdl.handle.net/2445/173106
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.talanta.2020.121994
dc.relation.ispartofTalanta, 2020, vol. 225, p. 121994
dc.relation.urihttps://doi.org/10.1016/j.talanta.2020.121994
dc.rightscc-by-nc-nd (c) Elsevier B.V., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Enginyeria Química i Química Analítica)
dc.subject.classificationEspectrometria de masses
dc.subject.classificationElectroforesi capil·lar
dc.subject.classificationAnàlisi d'orina
dc.subject.otherMass spectrometry
dc.subject.otherCapillary electrophoresis
dc.subject.otherUrine analysis
dc.titleEnantiodetermination of R,S-3,4-methylenedioxypyrovalerone in urine samples by high pressure in-line solid-phase extraction capillary electrophoresis-mass spectrometry
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
704991.pdf
Mida:
999.82 KB
Format:
Adobe Portable Document Format